Thomas Dee and Brian Kaspar Elected to New Board Roles
Thomas Dee and Brian Kaspar, PhD, two proven experts in [...]
Leading gene therapy expert Brian Kaspar joins Scientific Advisory Board
ENDSULIN is fast-tracking acceleration of our treatment as we continue [...]
Pioneering gene therapy CFO Thomas Dee joins board
Thomas Dee, previous Chief Finance Officer of blockbuster gene therapy [...]